Nicotine / THR - Statements from Experts: Difference between revisions

Jump to navigation Jump to search
Line 1,375: Line 1,375:
<br>
<br>
[[file:US Scott Ballin, JD.png|center|alt=Scott D. Ballin, JD, Health Policy Consultant. Former VP and Legislative Counsel, American Heart Association. Former Chairman of the Coalition on Smoking OR Health (precursor to CTFK): "On the issue of flavorings, any concerns about flavoring and youth initiation should be balanced with ensuring that significantly lower risk products such as cigarettes are consumer acceptable to the millions of smokers looking to quit. This obviously involves flavorings and palatability. Nicotine replacement therapies (NRT) have long been available in a wide variety of flavors..."|Scott D. Ballin, JD, Health Policy Consultant. Former VP and Legislative Counsel, American Heart Association. Former Chairman of the Coalition on Smoking OR Health (precursor to CTFK).]]
[[file:US Scott Ballin, JD.png|center|alt=Scott D. Ballin, JD, Health Policy Consultant. Former VP and Legislative Counsel, American Heart Association. Former Chairman of the Coalition on Smoking OR Health (precursor to CTFK): "On the issue of flavorings, any concerns about flavoring and youth initiation should be balanced with ensuring that significantly lower risk products such as cigarettes are consumer acceptable to the millions of smokers looking to quit. This obviously involves flavorings and palatability. Nicotine replacement therapies (NRT) have long been available in a wide variety of flavors..."|Scott D. Ballin, JD, Health Policy Consultant. Former VP and Legislative Counsel, American Heart Association. Former Chairman of the Coalition on Smoking OR Health (precursor to CTFK).]]
<br>
===Ronald Bayer, PhD===
*[https://www.publichealth.columbia.edu/people/our-faculty/rb8 Photo and Bio] / [https://www.statnews.com/2017/05/08/ecigarettes-harm-reduction-big-tobacco/ Quote Source]
<br>
[[file:US Bayer and Fairchild.png|center]]
<br>
<br>